Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5442049 | NOVARTIS | Oligonucleotides for modulating the effects of cytomegalovirus infections |
Aug, 2012
(11 years ago) | |
US5595978 | NOVARTIS | Composition and method for treatment of CMV retinites |
Aug, 2012
(11 years ago) |
Market Authorisation Date: 26 August, 1998
Treatment: Treatment of cmv retinitis by intravitreal admin of a phosphorothioate oligonucleotide capable of hybridizing with cmv mrna
Dosage: INJECTABLE;INJECTION